Herbalife Ltd. (HLF)
Herbalife Ltd. (HLF) is a global nutrition and direct selling company that develops and markets health and weight management products, nutritional supplements, and personal care items. Founded in 1980, the company operates through a network of independent distributors who sell its products worldwide. Herbalife emphasizes a balanced lifestyle and entrepreneurial opportunities for its independent members.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 18, 2014 | $0.30 | 2014-02-28 | 2014-03-04 |
| November 26, 2013 | $0.30 | 2013-11-07 | 2013-11-12 |
| August 27, 2013 | $0.30 | 2013-08-09 | 2013-08-13 |
| May 28, 2013 | $0.30 | 2013-05-10 | 2013-05-14 |
| March 19, 2013 | $0.30 | 2013-03-01 | 2013-03-05 |
Dividends Summary
- Herbalife Ltd. has issued 28 dividend payments over the past 7 years
- The most recent dividend was paid 4238 days ago, on March 18, 2014
- The highest dividend payed out to investors during this period was $0.30 per share
- The average dividend paid during this period was $0.24 per share.
Company News
Herbalife, a multilevel nutrition-supplement company, reported better-than-expected Q3 results, leading to an 11% jump in its share price despite a decline in the broader market. The company's adjusted net income and revenue beat analyst estimates, and it also provided an improved annual guidance.
The global pre-workout supplements market is expected to grow from $16.3 billion in 2024 to $26.7 billion by 2030, driven by rising demand for performance-enhancing supplements, increased health consciousness, and the expansion of fitness facilities.
The global dietary supplements market is projected to reach $283 billion by 2031, growing at a CAGR of 7.4%. The growth is driven by rising health consciousness and adoption of poor lifestyles, leading to increased demand for personalized nutrition.
CVS Health has seen a substantial 24% decline in the past three months, trading below its 50-day and 200-day moving averages. The company is grappling with the industry-wide pharmacy reimbursement crisis and labor shortages, but its 2025 roadmap and strategic initiatives offer a potential pathway to recovery.
Outspoken investor renews some of this Herbalife accusations.